Oxybee

RSS

oxalic acid dehydrate

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Oxybee. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Oxybee.

For practical information about using Oxybee, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 13/03/2018

Authorisation details

Product details
Name
Oxybee
Agency product number
EMEA/V/C/004296
Active substance
oxalic acid dehydrate
International non-proprietary name (INN) or common name
oxalic acid dehydrate
Species
Bees
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AG03
Publication details
Marketing-authorisation holder
Dany Bienenwohl GmbH
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
01/02/2018
Contact address
Geyerspergerstrasse 27
80689 Munich
Germany

Product information

01/02/2018 Oxybee - EMEA/V/C/004296 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Ectoparaciticides, insecticides and repellents
  • Ectoparaciticide for topical use, incl. insecticides

Therapeutic indication

For the treatment of varroosis (Varroa destructor) of honey bees (Apis mellifera) in brood-free colonies.

Assessment history

How useful was this page?

Add your rating